Australia markets closed

Kura Oncology, Inc. (KURA)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
14.70-0.16 (-1.08%)
At close: 04:00PM EST
14.70 0.00 (0.00%)
After hours: 04:02PM EST
Full screen
Trade prices are not sourced from all markets
Previous close14.86
Bid0.00 x 800
Ask0.00 x 800
Day's range14.65 - 15.18
52-week range10.41 - 19.93
Avg. volume1,035,062
Market cap983.386M
Beta (5Y monthly)0.85
PE ratio (TTM)N/A
EPS (TTM)-1.99
Earnings date22 Feb 2023 - 27 Feb 2023
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est28.67
  • Zacks

    Is Kura Oncology (KURA) Stock Outpacing Its Medical Peers This Year?

    Here is how Kura Oncology (KURA) and UnitedHealth Group (UNH) have performed compared to their sector so far this year.

  • GlobeNewswire

    Kura Oncology to Participate in Two Upcoming Investor Conferences

    SAN DIEGO, Nov. 22, 2022 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, today announced that Troy Wilson, Ph.D., J.D., President and Chief Executive Officer, is scheduled to participate in two upcoming investor conferences: A fireside chat at the Evercore ISI HealthCONx Conference at 12:35 p.m. ET / 9:35 a.m. PT on November 29, 2022; andA fireside chat at the

  • Zacks

    Wall Street Analysts Think Kura Oncology (KURA) Could Surge 116%: Read This Before Placing a Bet

    The average of price targets set by Wall Street analysts indicates a potential upside of 115.6% in Kura Oncology (KURA). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.